Interventional device developer Boston Scientific reported that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its Taxus Express² paclitaxel-eluting coronary stent system in Japan.
The Natick, MA-based company plans to launch the product in the country after reimbursement approval is granted.
By AuntMinnie.com staff writers
April 3, 2007
Related Reading
Boston Scientific shows year-end, Q4 sales growth, February 1, 2007
FDA OKs longer shelf life for Taxus, January 18, 2007
Boston Scientific launches Promus, January 11, 2007
Boston Scientific buys EndoTex, January 4, 2007
Boston Scientific receives FDA nod for FilterWire EZ, December 14, 2006
Copyright © 2007 AuntMinnie.com